Luteolin and fisetin suppress oxidative stress by modulating sirtuins and forkhead box O3a expression under <i>in vitro</i> diabetic conditions

Abstract

The results of our study supports current researches that state fisetin and luteolin as potential agents for the development of novel strategies for diabetes.